Regencell Bioscience Holdings Limited RGC
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | -51.86% | 0.00% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 0.00% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 0.00% |
| Total Current Assets | 0.00% | -51.92% | 0.00% | -25.56% | 0.00% |
|
|
|||||
| Total Current Assets | 0.00% | -51.92% | 0.00% | -25.56% | 0.00% |
| Net Property, Plant & Equipment | 0.00% | -25.94% | 0.00% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.43% | 0.00% | -89.58% | 0.00% |
| Total Assets | 0.00% | -47.64% | 0.00% | -23.05% | 0.00% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 0.00% | 304.02% | 0.00% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | -17.49% | 0.00% | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | -96.00% | 0.00% | -- | -- |
| Total Other Current Liabilities | 0.00% | -96.00% | 0.00% | -- | -- |
| Total Current Liabilities | 0.00% | 150.99% | 0.00% | -- | -- |
|
|
|||||
| Total Current Liabilities | 0.00% | 150.99% | 0.00% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | -44.65% | 0.00% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00% |
| Total Liabilities | 0.00% | 100.38% | 0.00% | 17.22% | 0.00% |
|
|
|||||
| Common Stock & APIC | 0.00% | 5.43% | 0.00% | 348.61% | 0.00% |
| Retained Earnings | 0.00% | -21.10% | 0.00% | -- | -- |
| Treasury Stock & Other | 0.00% | 61.88% | 0.00% | -- | -- |
| Total Common Equity | 0.00% | -74.91% | 0.00% | -27.62% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.00% | -74.91% | 0.00% | -27.62% | 0.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | -74.91% | 0.00% | -27.62% | 0.00% |
|
|
|||||